Machine learning early warning system reduces non-palliative deaths in general medicine unit

A study on CHARTwatch reveals its effectiveness in predicting patient deterioration, leading to reduced non-palliative care mortality in general medicine units.

Abcam finds founder’s opposition to Danaher deal ‘surprising,’ saying he’s sowing ‘confusion for shareholders’

Abcam founder Jonathan Milner said he’d vote against Danaher’s proposed buyout of the biopharma tools supplier on Thursday, and the UK company appeared dumbfounded by

September 16, 2023

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit – Psychedelic Alpha

NEW YORK and BERLIN, Oct. 06, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of

October 31, 2023

Alexion and Verge enter AI-powered drug discovery deal

Alexion and Verge Genomics will focus on detecting drug targets for rare neurodegenerative and neuromuscular ailments. Credit: Yurchanka Siarhei/Shutterstock.com. Alexion, AstraZeneca Rare Disease has entered

September 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.